FSI
LSB

Flow State Investments’s LakeShore Biopharma LSB Stock Holding History

Flow State Investments’s Portfolio LSB Stock Details LSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,966
Closed -$40.9K – 236
2023
Q2 		$40.9K Buy
2,966
+966
+48% +$14.3K 0.02% 95
2023
Q1 		$32K Buy
+2,000
New +$101K 0.03% 72

Other funds holding LSB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
VAM
Valliance Asset Management Central, Hong Kong $122M AUM 362.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
SLM
Snow Lake Management Menlo Park, California $90.7M AUM 72.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PAM
Pinpoint Asset Management Hong Kong $576M AUM 43.65% 1-Year Est. Return

Flow State Investments's LSB Position: Q3 2023 in Review

Flow State Investments sold out of LakeShore Biopharma (LSB) in Q3 2023, closing a stake of 2,966 shares — an estimated $40.9K sold.

Flow State Investments first reported a position in LSB in Q1 2023 and held it in 2 quarters. The position peaked at $40.9K in Q2 2023. 12 funds tracked by Wall St. Rank hold LSB as of Q3 2023.

  • Flow State Investments reported no remaining LakeShore Biopharma position as of Q3 2023 after selling out during the quarter.
  • Flow State Investments sold 2,966 LakeShore Biopharma shares in Q3 2023, an estimated $40.9K.
  • Flow State Investments first reported a position in LakeShore Biopharma in Q1 2023 and held it in 2 quarters.
  • Flow State Investments's LakeShore Biopharma position peaked at $40.9K in Q2 2023.
  • 12 funds tracked by Wall St. Rank held LakeShore Biopharma as of Q3 2023.

Based on Flow State Investments's 13F filing for Q3 2023, filed 14 Nov 2023.